VivoSeq
Other

Low Birth Weight

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Low Birth Weight is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

82/100

Attrition Rate

14/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

29

clinical trials

Completed18 · 62%
Unknown status5 · 17%
Terminated4 · 14%
Not yet recruiting1 · 3%
Recruiting1 · 3%

Trial Activity

29 trials

Enteral Zinc Supplementation in Very Low Birth Weight Infants
Not yet recruiting·UUniversity of Tennessee·Phase 3·NCT06433674·50 enrolled
Timing of Iron Supplementation in Very Low Birth Weight Infants
Completed··N/A·NCT00683527·46 enrolled
Erythropoietin Treatment in Extremely Low Birth Weight Infants
Completed··N/A·NCT00593801·219 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)